https://www.selleckchem.com/pr....oducts/AZD1152-HQPA.
ecurrences/y). No difference in postvaccination recurrences was found between patients with newly diagnosed and recurrent RRP. In this nonrandomized clinical trial, the frequency of RRP recurrences was significantly lower after HPV vaccination, and patients with RRP thus had a reduced burden of disease. Because no difference was detected in the frequency of recurrent postvaccination lesions in patients with new and recurrent disease, it appears that both groups showed equal benefit following HPV vaccination. These findings suggest